Allopurinol Sodium
Drug - Allopurinol Sodium
The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Allopurinol Sodium
Multiple ingredients are in alphabetical order.
Strength -
EQ 500MG BASE/VIAL
The potency of the active ingredient(s), Allopurinol Sodium. May repeat for multiple part products.
Applicant -
BEDFORD LABS
The firm name holding legal responsibility for Allopurinol Sodium. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
076870
The FDA assigned number to Allopurinol Sodium. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Allopurinol Sodium. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Aug 26, 2004
The date Allopurinol Sodium was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Allopurinol Sodium. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Allopurinol Sodium is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Bedford Laboratories
The full name of the firm holding legal responsibility for the new application of Allopurinol Sodium.
Allopurinol Sodium
|
